Dr Reddy's Laboratories Articles

Better 2nd-qtrs for most Indian drugmakers

8 August 2005

Healthscope buys full ownership of Pathnet

18 July 2005

UPDATE: Sanofi-Aventis reports forecast-beating earnings, 1st-qtr sales up 11.9%

23 May 2005

Update on Sanofi-Aventis US Plavix patent litigation

16 May 2005

Plavix patent trial rescheduled again

16 May 2005

Dr Reddy's Labs sees FY2005 profits slump

16 May 2005

US court upholds Lilly's Zyprexa patent

25 April 2005

Sanofi says US Plavix trial is rescheduled

4 April 2005

Dr Reddy's/ICICI in $56M deal on ANDAs

4 April 2005

Sanofi-Aventis/B-MS win Plavix patent battle in Canada

28 March 2005

Update on Sanofi-Aventis' Plavix patent litigation

28 February 2005

Dr Reddy's starts trials of CV drug in Ireland

14 February 2005

Dr Reddy's revenues fall 8%, net plunges

7 February 2005

Novo Nordisk halts DRF 2593 development

1 November 2004

Novartis prevails in Lamisil patent dispute with Dr Reddy's

13 September 2004

Indian results show generics losing shine

16 August 2004

Indian firms pay high cost for generics

12 July 2004

Dr Reddy's looking to acquire US firms

12 July 2004

Four drugmakers gain US appro for generic Cipro

14 June 2004

Dr Reddy's sees full-year sales climb 11%

7 June 2004

Dr Reddy's files ANDA for moxifloxacin tabs

5 April 2004

Dr Reddy's files for US generic levetiracetam

29 March 2004

Dr Reddy's names Dennis Langer president, North America

26 January 2004

Dr Reddy's organizes India's biggest pharma symposium

26 January 2004

Dr Reddy's opens S African subsidiary

17 November 2003

Sanofi-Synthelabo ups forecast on strong 1st-half, but fears persist over key patent

8 September 2003

Dr Reddy's Zoloft generic case dismissed in USA

21 July 2003

Dr Reddy's and Nicholas Piramel withdraw nimesulide products

9 June 2003

Profits up at Dr Reddy's in fourth quarter

9 June 2003

Dr Reddy's Allegra clone

31 March 2003

Lilly's Zyprexa faces new patent challenge

17 March 2003

Dr Reddy's and Leiner enter 15-year OTC drug deal

3 March 2003

Dr Reddy's first own-label brand in USA

13 January 2003

Bayer looks safe from generic Cipro in USA until late 2003, after appeal verdict

19 August 2002

Results improve at Indian pharma companies, powered by export performance

19 August 2002

Novo Nordisk stops ragaglitazar trials

29 July 2002

Dr Reddy's files for generic Lamisil in USA

29 July 2002

More generics take on Elan's Zanaflex

8 July 2002

Pfizer sues Dr Reddy's over Norvasc variant

1 July 2002

Huge leap in net profit at Dr Reddy's

10 June 2002

Plavix defense extends to include Dr Reddy's

10 June 2002

Dr Reddy's completes Phase I trial of DRF-1042

20 May 2002

Sanofi-Synthelabo to defend US clopidogrel patents

8 April 2002

Dr Reddy's files ANDA for generic Norvasc

4 March 2002

Huge increase in profits at Dr Reddy's

4 February 2002

Dr Reddy's gets Indian OK for zafirlukast

28 January 2002

Dr Reddy's gains zafirlukast OK in India

7 January 2002

Dr Reddy's gains zafirlukast OK in India

20 December 2001

Dr Reddy's signs up for Incyte database

29 November 2001

Andrx generic Prilosec approved in USA

19 November 2001

Novo Nordisk starts Ph II on DRF-2725

8 November 2001

Novartis' pipeline still a leader in pharma sector, despite recent setbacks

8 November 2001

Dr Reddy's reports huge rise in profits thanks to generic Prozac

2 November 2001

DGCI asks Dr Reddy's to recall cancer drug

1 October 2001

Dr Reddy to seek approval for generic Zofran in USA

30 August 2001

Dr Reddy's to launch famotidine in USA

24 August 2001

Indian pharma funds up 20% in past month, survey shows

15 August 2001

Update - Dr Reddy's gets OK for Prozac/Prilosec copies

3 July 2001

Dr Reddy's get tentative OK for two drugs in USA

29 June 2001

Pharma Res to market generic Prozac

1 June 2001

Dr Reddy net profits increase 55% in fiscal 2001

31 May 2001

Wockhardt to focus on genomics

30 May 2001

Strand Genomics deal with Dr Reddy's, et al

10 April 2001

8 bulk drugs under price control in India

11 December 2000

SB to take Indian firms to court over Avandia?

5 December 2000

Dr Reddy's buys female health brands

18 September 2000

Fiscal 1st-qtr results reveal strong results for India's pharmaceutical

8 August 2000

Dr Reddy's three-way JV for China

24 July 2000

Soon-to-be-merged Dr Reddy's and Cheminor post lackluster 1st-qtr sales

13 July 2000

Dr Reddy's launches Irnocam in India

7 July 2000

Mergers needed, says Dr Reddy's boss

29 June 2000

Indian shares up on R&D funding and liberalized imports news

17 April 2000

Indian industry, govt view pharma prospects

3 March 2000

Dr Reddy's to acquire 45% stake in AR

29 November 1999

Dr Reddy's may appeal against lawsuit decision

24 November 1999

Strong reporting period in the main for India's pharmaceutical companies

26 October 1999

Dr Reddy's profits

29 April 1999

Tough time ahead for Indian pharma firms

26 March 1999

Local demand boosts Indian pharma firms

2 February 1999

India's Dr Reddy's To Float JV In Brazil

9 October 1998

Dr Reddy's 1997-98 Profits Climb 45%

5 May 1998

3rd Qtr Turnover Up 33% At Dr Reddy's

23 February 1998

Ranbaxy/Dr Reddy's Collaborate On Antiulcerant Levant

14 November 1997

Indian Company To Launch New Division

4 December 1995

First Indo/Russian Pharma Venture Launched

23 October 1995

Dr Reddy's completes two acquisitions